IperionX Limited Sponsored ADR (NASDAQ:IPX – Get Free Report) has been given an average rating of “Moderate Buy” by the seven ratings firms that are covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell rating and six have issued a buy rating on the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $46.50.
IPX has been the subject of several research analyst reports. Jefferies Financial Group initiated coverage on IperionX in a research report on Wednesday, September 2nd. They issued a “buy” rating and a $26.00 price objective for the company. Roth Capital set a $53.00 target price on IperionX in a report on Wednesday, August 5th. BTIG Research raised their target price on IperionX from $40.00 to $55.00 and gave the company a “buy” rating in a research note on Friday, June 5th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of IperionX in a report on Friday, July 17th.
Get Our Latest Report on IperionX
IperionX Price Performance
Insider Transactions at IperionX
In related news, CEO Anastasios Arima bought 138,720 shares of the company’s stock in a transaction on Friday, July 10th. The stock was bought at an average cost of $3.58 per share, with a total value of $496,617.60. Following the completion of the purchase, the chief executive officer owned 12,455,502 shares in the company, valued at approximately $44,590,697.16. The trade was a 1.13% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Chairman Todd Hannigan bought 300,000 shares of IperionX stock in a transaction dated Monday, July 13th. The shares were bought at an average price of $3.59 per share, for a total transaction of $1,077,000.00. Following the completion of the transaction, the chairman directly owned 26,633,334 shares of the company’s stock, valued at $95,613,669.06. This represents a 1.14% increase in their position. The SEC filing for this purchase provides additional information. In the last three months, insiders have acquired 663,720 shares of company stock worth $2,379,118.
Institutional Trading of IperionX
Hedge funds and other institutional investors have recently modified their holdings of the stock. Private Advisor Group LLC raised its position in IperionX by 69.9% in the 1st quarter. Private Advisor Group LLC now owns 63,111 shares of the company’s stock worth $1,643,000 after purchasing an additional 25,964 shares during the last quarter. Corigliano Investment Advisers LLC acquired a new stake in shares of IperionX in the 4th quarter valued at $362,000. XY Capital Ltd acquired a new stake in shares of IperionX in the 4th quarter valued at $290,000. DLD Asset Management LP bought a new stake in shares of IperionX during the first quarter worth $260,000. Finally, Connective Capital Management LLC bought a new stake in shares of IperionX during the second quarter worth $160,000. Institutional investors and hedge funds own 2.76% of the company’s stock.
About IperionX
IperionX Limited (NASDAQ: IPX) is a materials technology company focused on developing a low-carbon, fully integrated titanium supply chain in the United States. The company is working to produce titanium metal and titanium products from locally sourced mineral resources, with applications across the aerospace, defense, automotive, medical and consumer industries.
IperionX’s flagship asset is the Titan Project in Tennessee, which contains titanium, rare earth and zircon-rich mineral sands.
Further Reading
- Five stocks we like better than IperionX
- Aeluma’s Selloff Could Be Setting Up Its Next Big Move
- Crypto Bill Stalls, Smart Money Calls: Time to Buy the Dip?
- The September Scramble: Find Sanctuary in These 3 Defensive Dividend Stocks
- The Fed’s Rate Hike Could Backfire If Oil Prices Collapse
Receive News & Ratings for IperionX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IperionX and related companies with MarketBeat.com's FREE daily email newsletter.
